arrow
Back
E

Eric N. Churchill

Takeda Development Center Americas, Inc.

17H-index
59Paper Count
2.2KCitation Count
Published Papers 20
Publication Date
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
err2025-12-01
err0
PREAI
errAhn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia
errShare
errSave
Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib
err2023-11-01
err1
PREAI
errMok, T. S. K.; Liu, G.; Nyaw, S. F.; Curcio, H.; Cortot, A.; Kam, T. Y.; Descourt, R.; Chik, Y. K.; Cheema, P. K.; Gwinnutt, J. M.; Churchill, E. N.; Nyborn, J.; Curran, E.; Yin, Y.; Chong, K.; Tanaka-Chambers, Y.; Kretz, J.; Cadranel, J.
errShare
errSave
Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy
err2021-09-01
err2
errOAAI
errYang, J. C-H.; Ramalingam, S. S.; Kim, T. M.; Kim, S-W.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Campelo, M. R. Garcia; Felip, E.; Bazhenova, L.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Churchill, E. N.; Mehta, M.; Janne, P. A.; Zhou, C.
errShare
errSave
Characterization of GI toxicities and their impact on efficacy in patients (pts) with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) treated with mobocertinib (TAK-788) who previously received platinum chemotherapy
err2021-09-01
err2
errOAAI
errNguyen, D.; Ramalingam, S. S.; Spira, A.; Riely, G. J.; Kim, T. M.; Yang, J. C-H.; Piotrowska, Z.; Campelo, M. R. Garcia; Felip, E.; Bazhenova, L.; Jin, S.; Griffin, C.; Diderichsen, P. M.; Gupta, N.; Bunn, V.; Lin, J.; Churchill, E. N.; Mehta, M.; Zhou, C.; Janne, P. A.
errShare
errSave
Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors
err2016-04-01
err10
errOAAI
errQvit, Nir; Schechtman, Deborah; Pena, Darlene Aparecida; Berti, Denise Aparecida; Soares, Chrislaine Oliveira; Miao, Qianqian; Liang, Liying (Annie); Baron, Lauren A.; Teh-Poot, Christian; Martinez-Vega, Pedro; Ramirez-Sierra, Maria Jesus; Churchill, Eric; Cunningham, Anna D.; Malkovskiy, Andrey V.; Federspiel, Nancy A.; Gozzo, Fabio Cesar; Torrecilhas, Ana Claudia; Manso Alves, Maria Julia; Jardim, Armando; Momar, Ndao; Dumonteil, Eric; Mochly-Rosen, Daria
errShare
errSave
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
err2011-12-01
err6
errOAAI
errMartin, Shiloh M.; Churchill, Eric; McKnight, Hayes; Mahaffey, Christopher M.; Ma, Yunpeng; O'Donnell, Robert T.; Tuscano, Joseph M.
errShare
errSave
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy
err2011-12-01
err34
errOAAI
errFerreira, Julio C. B.; Koyanagi, Tomoyoshi; Palaniyandi, Suresh S.; Fajardo, Giovanni; Churchill, Eric N.; Budas, Grant; Disatnik, Marie-Helene; Bernstein, Daniel; Brum, Patricia C.; Mochly-Rosen, Daria
errShare
errSave
Mitochondrial import of PKCε is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury
err2010-06-16
err132
errOAAI
errBudas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Sun, Lihan; Mochly-Rosen, Daria
errShare
errSave
Ischaemic preconditioning improves proteasomal activity and increases the degradation of δPKC during reperfusion
err2009-10-10
err78
errOAAI
errChurchill, Eric N.; Ferreira, Julio C.; Brum, Patricia C.; Szweda, Luke I.; Mochly-Rosen, Daria
errShare
errSave
Rationally designed peptide regulators of protein kinase C
err2009-01-01
err102
errOAAI
errChurchill, Eric N.; Qvit, Nir; Mochly-Rosen, Daria
errShare
errSave
PKC Isozymes in chronic cardiac disease: Possible therapeutic targets?
err2008-02-01
err135
PREAI
errChurchill, Eric; Budas, Grant; Vallcntin, Alice; Koyanag, Tornoyoshi; Mochly-Rosen, Daria
errShare
errSave
Nanoparticles: Novel cardioprotective devices that utilize a preconditioning-like mechanism
err2006-06-01
err0
PREAI
errChurchill, Eric N.; Bright, Rachel; Bright, Corinne; Leong, Kam; Szweda, Luke; Mochly-Rosen, Daria
errShare
errSave
Reperfusion-induced translocation of δPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation
err2005-07-08
err124
PREAI
errChurchill, EN; Murriel, CL; Chen, CH; Mochly-Rosen, D; Szweda, LI
errShare
errSave